WHO Approves New Malaria Vaccine for Children

The World Health Organization (WHO) has prequalified a new malaria vaccine for children, known as RTS,S. This vaccine has been developed by GlaxoSmithKline and has undergone rigorous testing. According to the WHO, the vaccine has shown a significant reduction in severe malaria cases and hospitalizations in young children. The prequalification process involves a thorough evaluation of the vaccine's safety, efficacy, and quality. The WHO's approval is a crucial step towards making the vaccine available in low- and middle-income countries. The vaccine will be distributed through the United Nations Children's Fund (UNICEF) and the WHO's Expanded Programme on Immunization. The first shipments are expected to arrive in the coming months.